The Viral and Eukaryotic Pathogens Special Emphasis Panel [IDM (12)] considers Small Business Innovation Research [SBIR] and Small Business Technology Transfer [STTR] grant applications that deal with the detection, characterization and inactivation of eukaryotic toxins, viruses, eukaryotic pathogens and their vectors, as well as sterilization and bioremediation technologies.

Specific areas covered by IDM (12):

• Innovations in methods or technologies for the detection or quantitation of toxins, viruses, eukaryotic pathogens, or their vectors
• Development of anti-infective, antiviral, antimicrobial or antiparasitic agents
• Testing novel therapeutic agents that target viral, microbial or parasitic diseases
• Development of traps, biocides or pesticides active against disease vectors
• Advances in sterilization, decontamination or disinfection technologies
• Development in and novel applications of bioremediation

IDM (12) has the following shared interests within the IDM IRG:

• With Small Business: Bacterial Diseases, Food Safety and General Microbiology [IDM (10)]: If an application focuses on the sterilization of foods or drinking water then assignment to IDM (10) may be appropriate. If the focus is on the sterilization of non-food items then assignment to IDM (12) may be appropriate.

IDM (12) has the following shared interests outside the IDM IRG:

• With the Biological Chemistry and Macromolecular Biophysics [BPC] IRG:  If an application deals with diagnostics, therapeutics, pharmacology or toxicology as applied to drug discovery of non-infectious diseases then assignment to BCMB may be appropriate. If the focus is on infectious diseases or their therapeutics then assignment to IDM (12) may be appropriate. If the focus is on eliminating nonpathogenic organisms or nontoxic compounds through bioremediation then assignment to BCMB may be appropriate. If the focus is on eliminating pathogenic organisms or toxic compounds then assigned to IDM (12) may be appropriate.
  
  
• With the Genes, Genomes and Genetics [GGG] IRG: If an application deals with pathogenic organisms in an evolutionary or population genetics context then assignment to GGG may be appropriate. If the main objective is the study of is detection, infection, therapeutics, molecular microbiology and physiology then assignment to IDM (12) may be appropriate.
  
  
• With the Bioengineering Sciences and Technologies [BST] IRG: If an application dealing with virology focuses primarily on developing technologies to introduce genes and drugs in a basic virology context or in developing viral vectors for delivery of genes, then assignment to BST may be appropriate. If the main focus is on detecting, characterizing or neutralizing pathogenic viruses then assignment to IDM (12) may be appropriate.
  
  
• With the AIDS and Related Research [AARR] IRG: If an application focuses on diagnostics, vaccines, or drug delivery mechanisms to combat AIDS-associated infectious diseases then assignment to AARR may be appropriate. If instead, the focus is on other non-bacterial infectious diseases then assignment to IDM (12) may be appropriate.
  
  
• With the Immunology [IMM] IRG: If an application dealing with host-pathogen responses focuses primary on the host immune response then assignment to IMM may be appropriate. If instead, the primary focus is on the pathogen then assignment to IDM (12) may be appropriate. In the event the focus is on host-pathogen interactions, assignment should be based on the central thrust of the application.
  
  
• With the Hematology [HEME] IRG: If the primary interest is in the blood cells then assignment to HEME may be appropriate. If the main objective is to study the parasite, and characteristics of the infection that relate to the parasite, then assignment to the IDM (12) may be appropriate.